{"id":"https://openalex.org/W2393410415","doi":null,"title":"Effects of rosiglitazone on renal TGF-\u03b2 and collagen-IV of diabetic rats","display_name":"Effects of rosiglitazone on renal TGF-\u03b2 and collagen-IV of diabetic rats","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W2393410415","mag":"2393410415"},"language":"en","primary_location":{"id":"mag:2393410415","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTOTAL-YIYA200903034.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764998623","display_name":"Jiangsu Medical Journal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4323283970","host_organization_name":"Jiangsu Pharmaceutical Editorial Department","host_organization_lineage":["https://openalex.org/P4323283970"],"host_organization_lineage_names":["Jiangsu Pharmaceutical Editorial Department"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Jiangsu Medical Journal","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100318082","display_name":"Wei Li","orcid":"https://orcid.org/0000-0001-9931-5990","observed_orcids":["https://orcid.org/0000-0001-9931-5990"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Wei Li","raw_affiliation_strings":["L\u00fc Shujun,et al"],"raw_orcid":"https://orcid.org/0000-0001-9931-5990","affiliations":[{"raw_affiliation_string":"L\u00fc Shujun,et al","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5100318082"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.37993126,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rosiglitazone","display_name":"rosiglitazone","score":1.0},{"id":"https://openalex.org/keywords/transforming-growth-factor-beta","display_name":"TGF-beta","score":0.8550000190734863},{"id":"https://openalex.org/keywords/type-iv-collagen","display_name":"type IV collagen","score":0.8730000257492065},{"id":"https://openalex.org/keywords/diabetic-nephropathy","display_name":"diabetic nephropathy","score":0.9850000143051147},{"id":"https://openalex.org/keywords/diabetic-rats","display_name":"diabetic rats","score":0.6269999742507935},{"id":"https://openalex.org/keywords/microalbuminuria","display_name":"microalbuminuria","score":0.9649999737739563},{"id":"https://openalex.org/keywords/renal-cortex","display_name":"renal cortex","score":0.7020000219345093},{"id":"https://openalex.org/keywords/renal-protection","display_name":"renal protection","score":0.6790000200271606},{"id":"https://openalex.org/keywords/blood-glucose","display_name":"blood glucose","score":0.4099999964237213}],"concepts":[{"id":"https://openalex.org/C2780152017","wikidata":"https://www.wikidata.org/wiki/Q424771","display_name":"Rosiglitazone","level":3,"score":0.929723858833313},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7558065056800842},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7085957527160645},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7062517404556274},{"id":"https://openalex.org/C2781203188","wikidata":"https://www.wikidata.org/wiki/Q1676817","display_name":"Microalbuminuria","level":3,"score":0.6348329782485962},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.5886512994766235},{"id":"https://openalex.org/C118131993","wikidata":"https://www.wikidata.org/wiki/Q423671","display_name":"Transforming growth factor","level":2,"score":0.5693644881248474},{"id":"https://openalex.org/C2779922275","wikidata":"https://www.wikidata.org/wiki/Q1129105","display_name":"Diabetic nephropathy","level":3,"score":0.5672435760498047},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.5115052461624146},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5101916790008545},{"id":"https://openalex.org/C2778577996","wikidata":"https://www.wikidata.org/wiki/Q2307492","display_name":"Renal cortex","level":3,"score":0.4870436489582062}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2393410415","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTOTAL-YIYA200903034.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764998623","display_name":"Jiangsu Medical Journal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4323283970","host_organization_name":"Jiangsu Pharmaceutical Editorial Department","host_organization_lineage":["https://openalex.org/P4323283970"],"host_organization_lineage_names":["Jiangsu Pharmaceutical Editorial Department"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Jiangsu Medical Journal","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9969000220298767,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2393676096","https://openalex.org/W3029575322","https://openalex.org/W2381820246","https://openalex.org/W2390896432","https://openalex.org/W2369596567","https://openalex.org/W2264799060","https://openalex.org/W2351278370","https://openalex.org/W2347867589","https://openalex.org/W2372631785","https://openalex.org/W2373446532"],"abstract_inverted_index":{"Objective":[0],"To":[1],"investigate":[2],"the":[3,46,63,89,96],"effects":[4],"of":[5,22,45,65,98],"rosiglitazone":[6],"on":[7,88],"renal":[8],"TGF-\u03b2":[9,66,99],"and":[10,38,42,50,62,67,80,100],"collagen-\u2163":[11,51,68],"in":[12,53,69,77,91],"diabetic":[13,29,92],"rats.Methods":[14],"Forty":[15],"rats":[16,30,93],"were":[17,40,56,72],"randomized":[18],"into":[19],"3":[20],"groups":[21],"normal":[23],"control":[24],"rats(group":[25,27],"C),diabetic":[26],"DC)and":[28],"treated":[31],"with":[32],"rosiglitazone(group":[33],"DR).After":[34],"10":[35],"weeks,blood":[36],"glucose":[37],"microalbuminuria":[39],"measured":[41],"pathologic":[43],"change":[44],"kidney":[47,90],"was":[48],"observed.TGF-\u03b2":[49],"expressions":[52,64],"kidneny":[54],"cortex":[55],"observed":[57],"by":[58],"immunohistochemistry.Results":[59],"Kidney":[60],"index,microalbuminuria":[61],"group":[70,78,81],"DC":[71],"significantly":[73],"higher":[74],"than":[75],"those":[76],"C":[79],"DR(P0.01).Conclusion":[82],"Rosiglitazone":[83],"has":[84],"a":[85],"protective":[86],"effect":[87],"through":[94],"downregulating":[95],"expression":[97],"collagen-\u2163.":[101]},"counts_by_year":[],"updated_date":"2025-10-10T17:16:08.811792","created_date":"2016-06-24T00:00:00"}